Literature DB >> 15765776

Autoantigenic epitopes on platelet glycoproteins.

Yoshiaki Tomiyama1, Satoru Kosugi.   

Abstract

Chronic immune thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by early platelet destruction mediated by antiplatelet autoantibodies. Platelet membrane glycoproteins (GP), especially GPIIb-IIIa and GPIb-IX, contain major autoantigenic determinants in chronic ITP. Recent advances in the localization of autoantigens as well as in the detection of GP-specific antibodies have improved our understanding of the pathophysiology of the disease. The N-terminal globular head of GPIIb-IIIa, particularly the beta-propeller domain in GPIIb, seems to play an important role as a hot spot for autoantigenic epitopes in chronic ITP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15765776     DOI: 10.1532/ijh97.04193

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  37 in total

Review 1.  Immune thrombocytopenic purpura.

Authors:  Douglas B Cines; Victor S Blanchette
Journal:  N Engl J Med       Date:  2002-03-28       Impact factor: 91.245

2.  Crystal structure of the extracellular segment of integrin alpha Vbeta3.

Authors:  J P Xiong; T Stehle; B Diefenbach; R Zhang; R Dunker; D L Scott; A Joachimiak; S L Goodman; M A Arnaout
Journal:  Science       Date:  2001-09-06       Impact factor: 47.728

Review 3.  The molecular immunology of human platelet proteins.

Authors:  T J Kunicki; P J Newman
Journal:  Blood       Date:  1992-09-15       Impact factor: 22.113

4.  Autoantibodies against platelet glycoprotein Ib/IX: a frequent finding in autoimmune thrombocytopenic purpura.

Authors:  V Kiefel; S Santoso; E Kaufmann; C Mueller-Eckhardt
Journal:  Br J Haematol       Date:  1991-10       Impact factor: 6.998

5.  A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia.

Authors:  T Sugiyama; M Okuma; F Ushikubi; S Sensaki; K Kanaji; H Uchino
Journal:  Blood       Date:  1987-06       Impact factor: 22.113

6.  Reactivity of autoantibodies from chronic ITP patients with recombinant glycoprotein IIIa peptides.

Authors:  R D Bowditch; P Tani; R McMillan
Journal:  Br J Haematol       Date:  1995-09       Impact factor: 6.998

7.  Platelet plasma membrane glycoproteins. Evidence for the presence of nonequivalent disulfide bonds using nonreduced-reduced two-dimensional gel electrophoresis.

Authors:  D R Phillips; P P Agin
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

Review 8.  Chronic idiopathic thrombocytopenic purpura.

Authors:  R McMillan
Journal:  N Engl J Med       Date:  1981-05-07       Impact factor: 91.245

9.  A prospective study of the usefulness of the measurement of platelet-associated IgG for the diagnosis of idiopathic thrombocytopenic purpura.

Authors:  J G Kelton; P J Powers; C J Carter
Journal:  Blood       Date:  1982-10       Impact factor: 22.113

10.  Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow.

Authors:  B Savage; F Almus-Jacobs; Z M Ruggeri
Journal:  Cell       Date:  1998-09-04       Impact factor: 41.582

View more
  5 in total

1.  Clinical significance of IPF% or RP% measurement in distinguishing primary immune thrombocytopenia from aplastic thrombocytopenic disorders.

Authors:  Mikiko Sakuragi; Satoru Hayashi; Miho Maruyama; Osamu Kabutomori; Tomoko Kiyokawa; Keisuke Nagamine; Hisashi Kato; Hirokazu Kashiwagi; Yuzuru Kanakura; Yoshiaki Tomiyama
Journal:  Int J Hematol       Date:  2015-01-25       Impact factor: 2.490

2.  Secondary immune thrombocytopenic purpura with renal cell carcinoma.

Authors:  Shigeaki Nakazawa; Masataka Kawamura; Kosuke Nakano; Norichika Ueda; Hidefumi Kishikawa; Hirokazu Kashiwagi; Motohide Uemura; Ryoichi Imamura; Kenji Nishimura; Norio Nonomura
Journal:  IJU Case Rep       Date:  2019-08-02

Review 3.  Pathophysiology and management of primary immune thrombocytopenia.

Authors:  Hirokazu Kashiwagi; Yoshiaki Tomiyama
Journal:  Int J Hematol       Date:  2013-05-24       Impact factor: 2.490

Review 4.  The Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and Pathogenesis.

Authors:  Rita Consolini; Annalisa Legitimo; Maria Costanza Caparello
Journal:  Front Pediatr       Date:  2016-10-19       Impact factor: 3.418

5.  Upregulation of cAMP prevents antibody-mediated thrombus formation in COVID-19.

Authors:  Jan Zlamal; Karina Althaus; Hisham Jaffal; Helene Häberle; Lisann Pelzl; Anurag Singh; Andreas Witzemann; Karoline Weich; Michael Bitzer; Nisar Malek; Siri Göpel; Hans Bösmüller; Meinrad Gawaz; Valbona Mirakaj; Peter Rosenberger; Tamam Bakchoul
Journal:  Blood Adv       Date:  2022-01-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.